Blue Jet Healthcare Limited (NSE:BLUEJET)
749.55
-29.40 (-3.77%)
Feb 21, 2025, 3:30 PM IST
Blue Jet Healthcare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | - | 409.54 | 654.38 | 753.73 | 611.27 | 100.72 |
Short-Term Investments | - | 320.84 | 49.96 | 0.27 | 0.05 | 1.1 |
Trading Asset Securities | - | 2,355 | 1,844 | 937.74 | 368.38 | 253.33 |
Cash & Short-Term Investments | 3,644 | 3,085 | 2,548 | 1,692 | 979.7 | 355.15 |
Cash Growth | 28.79% | 21.09% | 50.61% | 72.68% | 175.86% | - |
Accounts Receivable | - | 1,769 | 2,394 | 2,274 | 1,440 | 1,185 |
Other Receivables | - | 144.03 | 18.12 | 23.29 | 38.03 | 39.06 |
Receivables | - | 1,913 | 2,412 | 2,298 | 1,478 | 1,264 |
Inventory | - | 1,298 | 1,257 | 1,050 | 1,177 | 690.14 |
Prepaid Expenses | - | 9.94 | 15.47 | 8.47 | 3.93 | 5.24 |
Other Current Assets | - | 749.46 | 418.5 | 435.27 | 261.45 | 173.51 |
Total Current Assets | - | 7,056 | 6,650 | 5,483 | 3,900 | 2,488 |
Property, Plant & Equipment | - | 3,188 | 1,815 | 1,599 | 1,415 | 1,092 |
Long-Term Investments | - | 150 | - | - | - | 83.57 |
Other Intangible Assets | - | 1.97 | 0.41 | - | 0.01 | 0.07 |
Long-Term Deferred Tax Assets | - | - | - | - | - | 15.45 |
Other Long-Term Assets | - | 192.18 | 155.11 | 51.18 | 47.46 | 74.9 |
Total Assets | - | 10,588 | 8,621 | 7,134 | 5,363 | 3,754 |
Accounts Payable | - | 303.01 | 537.85 | 565.49 | 595.33 | 520.14 |
Accrued Expenses | - | 179.02 | 99.66 | 79.63 | 70.8 | 49.72 |
Short-Term Debt | - | - | - | - | 71.28 | 178.38 |
Current Portion of Long-Term Debt | - | - | - | - | 157.56 | 228 |
Current Portion of Leases | - | 12.34 | 18.91 | 40.22 | 0.49 | 0.08 |
Current Income Taxes Payable | - | 1,241 | 809.36 | 851.14 | 499.37 | 42.11 |
Current Unearned Revenue | - | - | 0.24 | 0.42 | - | 0.44 |
Other Current Liabilities | - | 324.74 | 272.77 | 208.14 | 236.16 | 313.51 |
Total Current Liabilities | - | 2,060 | 1,739 | 1,745 | 1,631 | 1,332 |
Long-Term Debt | - | - | - | - | 286.68 | 369.27 |
Long-Term Leases | - | 3.79 | 15.49 | 132.95 | 0.14 | - |
Long-Term Deferred Tax Liabilities | - | 31.6 | 10.2 | 2.64 | 13.8 | - |
Other Long-Term Liabilities | - | 24.67 | 19.43 | 22.77 | 15.52 | 10.62 |
Total Liabilities | - | 2,136 | 1,806 | 1,918 | 1,965 | 1,726 |
Common Stock | - | 346.93 | 346.93 | 346.93 | 99.12 | 6 |
Additional Paid-In Capital | - | - | - | - | 95.23 | 95.23 |
Retained Earnings | - | 8,105 | 6,468 | 4,868 | 3,204 | 1,820 |
Comprehensive Income & Other | - | - | - | - | - | 93.12 |
Total Common Equity | 9,240 | 8,452 | 6,815 | 5,215 | 3,398 | 2,014 |
Minority Interest | - | - | - | - | - | 13.26 |
Shareholders' Equity | 9,240 | 8,452 | 6,815 | 5,215 | 3,398 | 2,027 |
Total Liabilities & Equity | - | 10,588 | 8,621 | 7,134 | 5,363 | 3,754 |
Total Debt | 10.78 | 16.13 | 34.4 | 173.17 | 516.15 | 775.73 |
Net Cash (Debt) | 3,633 | 3,069 | 2,514 | 1,519 | 463.55 | -420.58 |
Net Cash Growth | 29.36% | 22.10% | 65.52% | 227.60% | - | - |
Net Cash Per Share | 20.96 | 17.69 | 14.49 | 8.75 | 2.67 | -2.42 |
Filing Date Shares Outstanding | 173.35 | 173.47 | 173.47 | 173.47 | 173.47 | 10.5 |
Total Common Shares Outstanding | 173.35 | 173.47 | 173.47 | 173.47 | 173.47 | 10.5 |
Working Capital | - | 4,997 | 4,912 | 3,738 | 2,269 | 1,156 |
Book Value Per Share | 53.21 | 48.73 | 39.29 | 30.07 | 19.59 | 191.82 |
Tangible Book Value | 9,238 | 8,450 | 6,814 | 5,215 | 3,398 | 2,014 |
Tangible Book Value Per Share | 53.20 | 48.71 | 39.28 | 30.07 | 19.59 | 191.82 |
Land | - | 22.37 | 21.43 | 13.41 | 0.1 | 0.1 |
Buildings | - | 460.46 | 493.06 | 437.41 | 418.65 | 304.46 |
Machinery | - | 2,009 | 1,544 | 1,304 | 1,137 | 914.42 |
Construction In Progress | - | 1,471 | 304.63 | 34.31 | 25.76 | 20.36 |
Source: S&P Capital IQ. Standard template. Financial Sources.